1) Gibberd FB, Billimoria JD, Goldman JM, et al:Heredopathia atactica polyneuritiformis:Refsum's disease. Acta Neurol Scand 1985;72(1):1-17 2) Lundberg A, Lilja LG, Lundberg PO, Try K:Heredopathia atactica polyneuritiformis (Refsum's disease). Experiences of dietary treatment and plasmapheresis. Eur Neurol 1972;8(6):309-24 3) Gibberd FB, Billimoria JD, Page NG, Retsas S:Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange. Lancet 1979;17(1):575-8 4) Hungerbühler JP, Meier C, Rousselle L, et al:Refsum's disease:management by diet and plasmapheresis. Eur Neurol 1985;24(3):153-9 5) Marroun I, Delèvaux I, André M, et al:Refsum's disease with severe neuropathy:efficiency of the diet and plasmapheresis. Rev Med Interne 2005;26(6):523-5 6) Gutsche HU, Siegmund JB, Hoppmann I:Lipapheresis:an immunoglobulin-sparing treatment for Refsum's disease. Acta Neurol Scand 1996;94(3):190-3 7) Straube R, Gäckler D, Thiele A, et al:Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome-an update of treatment modalities and pathophysiological cognition. Transfus Apher Sci 2003;29(1):85-91 8) Zolotov D, Wagner S, Kalb K, et al:Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis. Clin Apher 2012;27(2):99-105 9) Penovich PE, Hollander J, Nusbacher JA, et al:Note on plasma exchange therapy in Refsum's disease. Adv Neurol 1978;21:151-3 10) Harari D, Gibberd FB, Dick JP, Sidey MC:Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis). J Neurol Neurosurg Psychiatry 1991;54(7):614-7 11) Dickson N, Mortimer JG, Faed JM, et al:A child with Refsum's disease:successful treatment with diet and plasma exchange. Dev Med Child Neurol 1989;31(1):92-7 12) Gibberd FB:Plasma exchange for Refsum's disease. Transfus Sci 1993;14(1):23-6 13) Leppert D, Schanz U, Burger J, et al:Long-term plasma exchange in a case of Refsum's disease. Eur Arch Psychiatry Clin Neurosci 1991;241(2):82-4 14) Weinstein R:Phytanic acid storage disease (Refsum's disease):clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management. J Clin Apher 1999;14(4):181-4 15) Moser HW, Braine H, Pyeritz RE, et al:Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease. Birth Defects Orig Artic Ser 1980;16(1):491-7